Intellia Therapeutics Inc Launch of New Universal CAR-T Company with Cellex and Blackstone Life Sciences Corporate Call Transcript
Good morning and welcome to Intellia Therapeutics Corporate Update Call. (Operator Instructions) Please be advised, this conference call is being recorded at the company's request.
I will now turn the conference over to Lina Li, Director of Investor Relations at Intellia. Please proceed.
Thank you, operator, and good morning, everyone.
Welcome to Intellia's corporate update call to discuss the establishment of a new universal CAR-T company. Earlier this morning, Intellia issued a joint press release with Blackstone Life Sciences and Cellex Cell Professionals detailing the terms of the venture. This release can be found on the Investors & Media section of Intellia's website at intelliatx.com. As a reminder, this call is being broadcast live and a replay will also be archived on the company's website.
Joining me on the call today are Dr. John Leonard, Chief Executive Officer; Dr. David Lebwohl, Chief Medical Officer; Dr. Laura Sepp-Lorenzino, Chief Scientific Officer; and Glenn
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |